Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 154 到 173 筆資料,總共 583 筆
< 上一頁
下一頁 >
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1991
Disruption of Cellular Energy Balance by Suramin in Intact Human Prostatic Carcinoma Cells, a Likely Antiproliferative Mechanism
Rago R.; Mitchen J.; ANN-LII CHENG
; Oberley T.; Wilding G.
Cancer Research
41
42
2008
Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy
Lin Y.-C.; LING-HUNG WEI
; CHIA-TUNG SHUN
; ANN-LII CHENG
; CHIH-HUNG HSU
Oncology
28
20
2012
Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma
YU-YUN SHAO
; Chen C.-L.; MING-CHIH HO
; Huang C.-C.; Tu H.-C.; CHIH-HUNG HSU
; ANN-LII CHENG
Anticancer Research
9
10
2014
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study
CHING-HUNG LIN
; Chuang P.-Y.; CHUN-JU CHIANG
; YEN-SHEN LU
; ANN-LII CHENG
; WEN-HUNG KUO
; CHIUN-SHENG HUANG
; Lai M.-S.; You S.-L.; Tang C.-H.
Oncologist
39
39
2017
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
Tsai K.-F.; JYH-MING LIOU
; MEI-JYH CHEN
; CHIEN-CHUAN CHEN
; SUNG-HSIN KUO
; I-RUE LAI
; KUN-HUEI YEH
; MING-TSAN LIN
; HSIU-PO WANG
; ANN-LII CHENG
; Lin J.-T.; CHIA-TUNG SHUN
; MING-SHIANG WU
PLoS ONE
29
25
2017
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
YI-HSIN LIANG
; Wei, C. H.; Hsu, W. H.; YU-YUN SHAO
; Lin, Y. C.; Chou, P. C.; ANN-LII CHENG
; KUN-HUEI YEH
Support Care Cancer
10
10
2012
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
Tai W.-T.; ANN-LII CHENG
; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN
; Chen K.-F.
Molecular Cancer Therapeutics
112
108
2012
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN
; ANN-LII CHENG
Biochemical Pharmacology
40
35
2008
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
Chen K.-F.; Yeh P.-Y.; KUN-HUEI YEH
; YEN-SHEN LU
; SHANG-YI HUANG
; ANN-LII CHENG
Cancer Research
114
105
2004
Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells
KUN-HUEI YEH
; ANN-LII CHENG
; Wan J.-P.; Lin C.-S.; Liu C.-C.
Anti-Cancer Drugs
37
33
2004
Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy
CHIH-HUNG HSU
; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN
; ANN-LII CHENG
Anticancer Research
47
41
2006
Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone
Yao C.-J.; Lai G.-M.; Chan C.-F.; ANN-LII CHENG
; Yang Y.-Y.; Chuang S.-E.
International Journal of Cancer
67
67
2015
Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer
YU-HSUAN CHEN
; Wei M.-F.; CHUN-WEI WANG
; Lee H.-W.; Pan S.-L.; Gao M.; SUNG-HSIN KUO
; ANN-LII CHENG
; Teng C.-M.
Cancer letters
42
39
2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
BANG-BIN CHEN
; YU-YUN SHAO
; ZHONG-ZHE LIN
; CHIH-HUNG HSU
; ANN-LII CHENG
; CHIUN HSU
; PO-CHIN LIANG
; TIFFANY TING-FANG SHIH
Diagnostics (Basel, Switzerland)
7
7
2011
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
CHAO-YU HSU
; Ying-Chun Shen
; CHIH-WEI YU
; CHIUN HSU
; Hu F.-C.; CHIH-HUNG HSU
; BANG-BIN CHEN
; Wei S.-Y.; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
Journal of Hepatology
106
100
2016
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
BANG-BIN CHEN
; CHAO-YU HSU
; CHIH-WEI YU
; PO-CHIN LIANG
; CHIUN HSU
; CHIH-HUNG HSU
; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
Radiology
27
25
2012
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
Kuo Y.-H.; CHING-HUNG LIN
; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG
; Huang S.-M.; CHIUN HSU
; YEN-SHEN LU
; ANN-LII CHENG
BMC Cancer
19
16
2010
E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: Possible correlation with stage and treatment response
Liu T.-Y.; SHEE-UAN CHEN
; SUNG-HSIN KUO
; ANN-LII CHENG
; CHUNG-WU LIN
Modern Pathology
43
40
2010
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma
YU-YUN SHAO
; ZHONG-ZHE LIN
; CHIUN HSU
; Ying-Chun Shen
; CHIH-HUNG HSU
; ANN-LII CHENG
Cancer
141
148
2019
Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
YU-YUN SHAO
; TSUNG-HAO LIU
; CHIUN HSU
; LI-CHUN LU
; YING-CHUN SHEN
; ZHONG-ZHE LIN
; ANN-LII CHENG
; CHIH-HUNG HSU
Liver International
56
58